Hubei sihuan pharmaceutical co., Ltd. is a tetracycline medicine industry co., Ltd. (stock code: 000605) of subsidiaries. registered capital of 45 million Yuan, mainly the production of chemical raw materials, such as tablets, capsules, granules, suppository dosage form.

company established in September 2002, complete the company registration, access to medication production enterprise license, business license, tax registration. set up a company Board of Directors, drawn up a Constitution, appointed General Manager of the company and senior management personnel. and scope of business includes raw materials (rufloxacin hydrochloride, joining General flavone), tablets and capsules. on March 12, 2003, increased the scope was changed suppositories. on April 19, 2006 was changed to increase drug songs United States he chlorpromazine hydrochloride granules and raw materials. after January 18, 2011 changes to increase raw materials (levofloxacin mesylate effects of levofloxacin, ofloxacin lactate).

after the company formed, followed the honest, proactive, continuous improvement philosophy, quickly built a high quality, high quality and efficient organization of modern pharmaceutical production quality management standard, GMP management has developed practical enterprise file systems, including all kinds of standard management program (SMP), standard work procedure (SOP)., and the actual production process management and operation of all acts were under control, all acts are based on all records.